CCCC
Price
$3.74
Change
+$0.03 (+0.81%)
Updated
Jan 23 closing price
Capitalization
264M
27 days until earnings call
FHTX
Price
$4.38
Change
+$0.01 (+0.23%)
Updated
Jan 23 closing price
Capitalization
243.5M
41 days until earnings call
Ad is loading...

CCCC vs FHTX

Header iconCCCC vs FHTX Comparison
Open Charts CCCC vs FHTXBanner chart's image
C4 Therapeutics
Price$3.74
Change+$0.03 (+0.81%)
Volume$1.71M
Capitalization264M
Foghorn Therapeutics
Price$4.38
Change+$0.01 (+0.23%)
Volume$61.83K
Capitalization243.5M
CCCC vs FHTX Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. FHTX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and FHTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (CCCC: $3.74 vs. FHTX: $4.38)
Brand notoriety: CCCC and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 44% vs. FHTX: 39%
Market capitalization -- CCCC: $264M vs. FHTX: $243.5M
CCCC [@Biotechnology] is valued at $264M. FHTX’s [@Biotechnology] market capitalization is $243.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $360.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while FHTX’s TA Score has 3 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 3 bearish.
  • FHTX’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -3.11% price change this week, while FHTX (@Biotechnology) price change was +4.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.00%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was -0.35%.

Reported Earning Dates

CCCC is expected to report earnings on May 08, 2025.

FHTX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+5.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($264M) has a higher market cap than FHTX($243M). CCCC YTD gains are higher at: 3.889 vs. FHTX (-7.203). FHTX (-98.53M) and CCCC (-103.45M) have comparable annual earnings (EBITDA) . FHTX (267M) and CCCC (256M) have equal amount of cash in the bank . FHTX has less debt than CCCC: FHTX (39.1M) vs CCCC (67.1M). CCCC has higher revenues than FHTX: CCCC (33.7M) vs FHTX (25.5M).
CCCCFHTXCCCC / FHTX
Capitalization264M243M109%
EBITDA-103.45M-98.53M105%
Gain YTD3.889-7.203-54%
P/E RatioN/AN/A-
Revenue33.7M25.5M132%
Total Cash256M267M96%
Total Debt67.1M39.1M172%
TECHNICAL ANALYSIS
Technical Analysis
CCCCFHTX
RSI
ODDS (%)
N/A
Bullish Trend 17 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 17 days ago
77%
N/A
Momentum
ODDS (%)
Bearish Trend 17 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 17 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 17 days ago
83%
Bearish Trend 17 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 17 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 30 days ago
86%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 26 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 17 days ago
90%
View a ticker or compare two or three
Ad is loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VEUAX30.860.36
+1.18%
JPMorgan Europe Dynamic A
CPAYX11.090.09
+0.82%
Integrity Dividend Summit C
SVFFX82.230.48
+0.59%
Smead Value I1
EILVX26.580.13
+0.49%
Eaton Vance Large-Cap Value I
GMCQX13.720.06
+0.44%
GMO US Equity VI

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+0.81%
KYMR - CCCC
60%
Loosely correlated
+0.23%
CRSP - CCCC
50%
Loosely correlated
+0.07%
FATE - CCCC
49%
Loosely correlated
N/A
PRME - CCCC
48%
Loosely correlated
+2.52%
BEAM - CCCC
47%
Loosely correlated
-0.38%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with CCCC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+0.23%
CCCC - FHTX
44%
Loosely correlated
+0.81%
NTLA - FHTX
44%
Loosely correlated
+2.54%
CRSP - FHTX
43%
Loosely correlated
+0.07%
ABOS - FHTX
43%
Loosely correlated
-1.14%
AVIR - FHTX
42%
Loosely correlated
-0.64%
More